Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BASIC
2018-003148-21Phase 3Active
- Sponsor
- NTNU
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cluster Headache (CH) comparing Botox with Placebo (2 arms). Started Jan 2019; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2018-003148-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003148-21.